“Background: The causal relationship between gout and renal transplant outcomes is difficult to assess due to multiple interacting covariates. This study sought to estimate the independent effect of new-onset gout on renal transplant outcomes using a methodology that accounted for these interactions.”
Read more, here.
“A genetic screening study found a higher-than-expected prevalence of undiagnosed Fabry disease in people who had kidney failure and transplant without a known cause.
When the screening was extended to related family members, additional unidentified cases were found and treated early.
The findings led researchers to recommend genetic screening for kidney transplant patients, particularly those with an unknown cause.”
Read more about the study, here.
“Following the first case of coronavirus infectious disease 2019 (COVID-19) in the USA in January 2020, New York quickly became the epicenter of the pandemic in March and April 2020. Initial results from 3 centers in New York reported a high mortality rate of 20%-39% in hospitalized patients 1, 2, 3. Kidney transplant recipients are expected to be at an increased risk of complications from COVID-19 not only due to their chronic immunosuppression but also frequently associated comorbidities including older age, hypertension, diabetes mellitus, chronic kidney disease and cardiovascular disease.”
Read the full study on kidney INTERNATIONAL, here.